Skip to main content
Erschienen in: Japanese Journal of Radiology 9/2013

01.09.2013 | Original Article

Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?

verfasst von: Chuanben Chen, Xiang Lin, Jianji Pan, Zhaodong Fei, Lisha Chen, Penggang Bai

Erschienen in: Japanese Journal of Radiology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Our aim was to evaluate the volumetric and dosimetric changes of target volumes and organs at risk (OARs) during intensity-modulated radiation therapy (IMRT) for locoregionally advanced nasopharyngeal carcinoma (NPC) and the necessity of replanning.

Materials and methods

Twenty locoregionally advanced NPC patients treated by concurrent chemotherapy and IMRT were included. CT and MR images were acquired before treatment and at weeks 2, 3, 4, 5 and 6 during treatment. The target volumes and OARs were contoured based on the fused CT-MRI images and hybrid plans were generated. The changes of volume and dosimetry were measured by comparing original plan and hybrid plans.

Results

Significant volumetric changes of target volumes and parotid gland were observed. The primary nasopharyngeal tumor (GTVnx), CTV1, involved lymph nodes (GTVnd) and left and right parotid glands, shrank at a mean rate of 14.7, 11.56, 11.40, 6.54 and 6.78 % per treatment week, respectively. There were no significant dosimetric changes in GTVnx, GTVnd, CTV1, spinal cord and brain stem while the differences of dose to left and right parotid glands were significant (F = 6.73, P = 0.007; F = 7.43, P = 0.007).

Conclusions

Remarkable volumetric changes were observed. However, the dosimetric changes were inconspicuous except for the parotid. Replanning might contribute to protect the parotid gland.
Literatur
1.
Zurück zum Zitat Bhide SA, Davies M, Burke K, McNair HA, Hansen V, Barbachano Y, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010;76(5):1360–8.PubMedCrossRef Bhide SA, Davies M, Burke K, McNair HA, Hansen V, Barbachano Y, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010;76(5):1360–8.PubMedCrossRef
2.
Zurück zum Zitat Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(2):355–62.PubMedCrossRef Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(2):355–62.PubMedCrossRef
3.
Zurück zum Zitat Robar JL, Day A, Clancey J, Kelly R, Yewondwossen M, Hollenhorst H, et al. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(4):1121–30.PubMedCrossRef Robar JL, Day A, Clancey J, Kelly R, Yewondwossen M, Hollenhorst H, et al. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(4):1121–30.PubMedCrossRef
4.
Zurück zum Zitat Rasch CRN, Steenbakkers RJHM, Fitton I, Duppen JC, Nowak PJ, Pameijer FA, et al. Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharynx cancer. Radiat Oncol. 2010;5:21.PubMedCrossRef Rasch CRN, Steenbakkers RJHM, Fitton I, Duppen JC, Nowak PJ, Pameijer FA, et al. Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharynx cancer. Radiat Oncol. 2010;5:21.PubMedCrossRef
5.
Zurück zum Zitat Castadot P, Geets X, Lee JA, Christian N, Gregoire V. Assessment by deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol. 2010;95(2):209–17.PubMedCrossRef Castadot P, Geets X, Lee JA, Christian N, Gregoire V. Assessment by deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol. 2010;95(2):209–17.PubMedCrossRef
6.
Zurück zum Zitat Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75(4):1071–8.PubMedCrossRef Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75(4):1071–8.PubMedCrossRef
7.
Zurück zum Zitat Zhang X, Li M, Cao J, Luo JW, Xu GZ, Gao L, et al. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. Br J Radiol. 2012;85(1016):e506–13.PubMedCrossRef Zhang X, Li M, Cao J, Luo JW, Xu GZ, Gao L, et al. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. Br J Radiol. 2012;85(1016):e506–13.PubMedCrossRef
8.
Zurück zum Zitat Chambers MS, Garden AS, Kies M, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.PubMedCrossRef Chambers MS, Garden AS, Kies M, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.PubMedCrossRef
9.
Zurück zum Zitat Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212.PubMedCrossRef Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212.PubMedCrossRef
10.
Zurück zum Zitat McMillan AS, Pow EH, Leung WK, Wong MC, Kwong DL. Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil. 2004;31(6):600–8.PubMedCrossRef McMillan AS, Pow EH, Leung WK, Wong MC, Kwong DL. Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil. 2004;31(6):600–8.PubMedCrossRef
11.
Zurück zum Zitat Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF. LOW DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55(2):312–21.PubMedCrossRef Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF. LOW DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55(2):312–21.PubMedCrossRef
12.
Zurück zum Zitat Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1117–26.PubMedCrossRef Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1117–26.PubMedCrossRef
13.
Zurück zum Zitat Teo PM, Leung SF, Tung SY, Zee B, Sham JS, Lee AW, et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong Nasopharyngeal Carcinoma. Study Group (HKNPCSG). Radiother Oncol. 2006;79(1):27–33.PubMedCrossRef Teo PM, Leung SF, Tung SY, Zee B, Sham JS, Lee AW, et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong Nasopharyngeal Carcinoma. Study Group (HKNPCSG). Radiother Oncol. 2006;79(1):27–33.PubMedCrossRef
14.
Zurück zum Zitat Leibel SA, Kutcher GJ, Harrison LB, Fass DE, Burman CM, Hunt MA, et al. Improved dose distributions for 3D conformal boost treatment in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991;20(4):823–33.PubMedCrossRef Leibel SA, Kutcher GJ, Harrison LB, Fass DE, Burman CM, Hunt MA, et al. Improved dose distributions for 3D conformal boost treatment in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991;20(4):823–33.PubMedCrossRef
15.
Zurück zum Zitat Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA. Dose–response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer. 1982;50(6):1042–50.PubMedCrossRef Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA. Dose–response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer. 1982;50(6):1042–50.PubMedCrossRef
16.
Zurück zum Zitat Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75(3):924–32.PubMedCrossRef Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75(3):924–32.PubMedCrossRef
17.
Zurück zum Zitat Fung WW, Wu VW, Teo PM. Dosimetric evaluation of a three-phase adaptive radiotherapy for nasopharyngeal carcinoma using helical tomotherapy. Med Dosim. 2012;37(1):92–7.PubMedCrossRef Fung WW, Wu VW, Teo PM. Dosimetric evaluation of a three-phase adaptive radiotherapy for nasopharyngeal carcinoma using helical tomotherapy. Med Dosim. 2012;37(1):92–7.PubMedCrossRef
18.
Zurück zum Zitat Wang W, Yang H, Hu W, Shan G, Ding W, Yu C, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):617–21.PubMedCrossRef Wang W, Yang H, Hu W, Shan G, Ding W, Yu C, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):617–21.PubMedCrossRef
19.
Zurück zum Zitat Yang H, Hu W, Ding W, Shan G, Wang W, Yu C, et al. Changes of the transverse diameter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for patients with nasopharyngeal carcinoma. Med Dosim. 2012;37(2):225–9.PubMedCrossRef Yang H, Hu W, Ding W, Shan G, Wang W, Yu C, et al. Changes of the transverse diameter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for patients with nasopharyngeal carcinoma. Med Dosim. 2012;37(2):225–9.PubMedCrossRef
Metadaten
Titel
Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
verfasst von
Chuanben Chen
Xiang Lin
Jianji Pan
Zhaodong Fei
Lisha Chen
Penggang Bai
Publikationsdatum
01.09.2013
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 9/2013
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-013-0225-5

Weitere Artikel der Ausgabe 9/2013

Japanese Journal of Radiology 9/2013 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.